Navigation Links
PETA files complaint with European ombudsman over animal testing for REACH
Date:7/27/2012

London The People for the Ethical Treatment of Animals (PETA) Foundation UK has submitted a complaint to the European ombudsman today alleging that the European Chemicals Agency (ECHA) is failing to fulfil its mandated responsibilities by not properly investigating cases in which animal testing could be avoided under the rules of REACH. The European ombudsman investigates complaints about maladministration in EU institutions and agencies, and PETA maintains that evidence derived from public documents and correspondence with the agency demonstrates that ECHA is not taking the necessary steps to ensure that REACH's legal requirement that animal testing be conducted only as a "last resort" are fulfilled.

The REACH Regulation (1907/2006/EU) makes clear in recitals, articles and annexes that animal tests must be avoided wherever possible, but in 2011 the agency's report "The Use of Alternatives to Testing on Animals for the REACH Regulation" showed that tens of thousands of animals were used in tests that could have been avoided under REACH's own rules. These tests included 135 skin-irritation studies conducted after a non-animal replacement had been validated and approved for use under REACH and 107 studies conducted without prior submission and approval of a testing proposal.

In response to the report, PETA UK contacted ECHA and the European Commission to seek assurances that all such possible violations of the requirements were being investigated by the agency and/or notified to relevant national authorities. These enquiries have revealed the following:

  1. ECHA is not taking action to investigate all the 107 tests conducted without test proposals and will not routinely investigate similar cases in the future.
  2. ECHA does not directly inform member state authorities of all possible violations of last-resort requirements identified by its own internal processes.
  3. During compliance checks, ECHA evaluates only whether or not adaptations to animal test requirements comply with the REACH Regulation, not whether animal tests themselves could have been avoided.

PETA UK has therefore submitted a complaint to the ombudsman, which notes that in failing to take appropriate action to evaluate compliance of animal tests with REACH's requirements, the agency is guilty of maladministration.

"REACH has multiple mechanisms to mitigate its massive impact on animals, but the European institution responsible for ensuring REACH compliance is simply not ensuring that all of those mechanisms are being implemented," says PETA UK policy adviser Alistair Currie. "We have pursued this issue with ECHA itself and with the European Commission but without resolution. With millions of animals' lives at stake, we trust that the ombudsman will take our view that the agency is failing to fulfil its obligations."


'/>"/>

Contact: Jessica Sandler
JessicaS@PETA.org
757-622-7382 x8001
People for the Ethical Treatment of Animals
Source:Eurekalert

Related biology news :

1. Alnylam and UMass Medical School announce Tuschl I patent upheld in European opposition proceedings
2. An invasive Asian fly is taking over European fruit
3. Building the European Unions Natura 2000 -- the largest ever network of protected areas
4. European grasslands challenge rainforests as the most species-rich spaces on Earth
5. European mountain plant population shows delayed response to climate change
6. European Society of Human Reproduction and Embryology 28th Annual Meeting -- Istanbul
7. Citizen science helps unlock European genetic heritage
8. Parkinsons disease stopped in animal model
9. Study suggests why some animals live longer
10. Are we really a nation of animal lovers?
11. NOAA discovers way to detect low-level exposure to seafood toxin in marine animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... This BCC Research report provides a ... the recent advances in high throughput ‘omic platforms ... forward. Includes forecast through 2019. Use ... opportunities that exist in the bioinformatic market. Analyze ... well as IT and bioinformatics service providers. Analyze ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... San Francisco, CA (PRWEB) , ... February 04, ... ... future of enterprise talent development and compliance training, today announced an interactive ... on Morf Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course ...
(Date:2/4/2016)... Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today that Edward Lanphier , Sangamo,s president and ... progress of Sangamo,s ZFP Therapeutic ® development programs ... 2:40 pm ET on Thursday, February 11, 2016, at ... Conference. The conference is being held in ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... Forensics Club, takes place February 5-6 at the University’s student center, Kehr ... activities such as workshops and competitions for ample networking, learning and collaborating ...
(Date:2/4/2016)... 2016  CytoSorbents Corporation (NASDAQ: CTSO ), ... CytoSorb® blood filter to treat deadly inflammation in ... announced that CEO Dr. Phillip Chan , ... Group,s 2016 Disruptive Growth & Healthcare Conference, providing ... Conference Presentation Details: Where: Convene Conference ...
Breaking Biology Technology: